US2008014286A1PendingUtilityA1
Metal-containing materials
Assignee: NUCRYST PHARMACEUTICALS CORP APriority: Jul 27, 2000Filed: Aug 14, 2007Published: Jan 17, 2008
Est. expiryJul 27, 2020(expired)· nominal 20-yr term from priority
A61K 2800/413A61K 9/0078A61P 1/02A61L 2300/606A61K 31/28A61P 17/00A61L 2300/404A61L 29/10A61L 17/145A61Q 19/00A61L 2300/104A61L 2300/624A61K 33/38A61L 27/30A61L 2300/102A61K 9/7023A61K 9/7007A61L 15/46A61Q 17/005A61K 9/14A61K 8/19A61L 31/082B82Y 5/00A61K 9/0024A61K 9/0014A61K 33/243A61K 33/242A61K 33/24
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Metal-containing materials, as well as their preparation and use are disclosed. The metal-containing material can be, for example, an antimicrobial material, an anti-biofilm material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, anti-proliferative, MMP modulating material, an atomically disordered, crystalline material, and/or a nanocrystalline material. In certain embodiments, the metal-containing material is an atomically disordered, nanocrystalline silver-containing material.
Claims
exact text as granted — not AI-modified1 . A nanocrystalline material, comprising:
a metal; and an element selected from the group consisting of oxygen, nitrogen, carbon, boron, sulfur, phosphorus, silicon, a halogen, hydrogen and combinations thereof, wherein the nanocrystalline material contains at least about one atomic percent of the element.
2 - 27 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.